Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

RSS Feed

Home
/
Medication

Medication Recalls

Browse drug and medication recalls including prescription drugs, OTC medications, and supplements. Stay informed about pharmaceutical safety alerts.

Get alerts for medication RSS feed

Showing 801–820 of 1639 recalls

Filter by date, severity, state →

Glimepiride Tablets 1mg 500-count (Dr. Reddy's) – Tablet Misprint (2024)

Misprint on tablet

Class IIILow

FDAJan 18, 2024Nationwide• Dr. Reddy's Laboratories, Inc.

Fosfomycin Tromethamine Granules (Ascend) – Impurity Specification (2024)

Failed Impurities/Degradation Specification: Out of specification for organic impurities

Class IIModerate

FDAJan 16, 2024Nationwide• Ascend Laboratories, LLC

Vasopressin Sodium Chloride (IntegraDose) – Subpotent Drug (2024)

Subpotent Drug

Class IIModerate

FDAJan 12, 2024MN• IntegraDose Compounding Services LLC

Vasostrict (Par Sterile Products) – Superpotent Drug (2024)

Superpotent Drug: Assay from the 3-month and 6-month stability intervals exceeded the upper specification limit.

Class IIModerate

FDAJan 11, 2024Nationwide• Par Sterile Products LLC

Budesonide Tablets (Teva) – Failed Dissolution (2024)

Failed Dissolution Specifications

Class IIModerate

FDAJan 8, 2024Nationwide• Teva Pharmaceuticals USA, Inc

Bupropion XL Tablets (Rising Pharma) – Foreign Tablets (2023)

Presence of Foreign Tablets/Capsules

Class IIModerate

FDADec 29, 2023Nationwide• Rising Pharma Holding, Inc.

Ibuprofen Famotidine Tablets (Ascend) – Foreign Tablet (2023)

Presence of Foreign Tablet/Capsule: A stray Rasagiline Mesylate 1 mg tablet was discovered in an unopened bottle of Ibuprofen and Famotidine.

Class IIModerate

FDADec 29, 2023Nationwide• Ascend Laboratories, LLC

DELFLEX Peritoneal Dialysis Solution (Fresenius) – Sterility Concern (2023)

Lack of Sterility Assurance

Class IIModerate

FDADec 28, 2023Nationwide• Fresenius Medical Care Holdings, Inc.

Benzonatate Capsules (Amerisource) – Superpotent Drug (2023)

Superpotent drug: Assay results were slightly above specification at the time zero point.

Class IIILow

FDADec 26, 2023Nationwide• Amerisource Health Services LLC

Robitussin Honey CF Max Non-Drowsy (Haleon) – Microbial Contamination (2023)

Microbial Contamination of Non-Sterile Products

Class IHigh

FDADec 26, 2023Nationwide• Haleon US Holdings LLC

Robitussin Honey CF Max Nighttime (Haleon) – Microbial Contamination (2023)

Microbial Contamination of Non-Sterile Products

Class IHigh

FDADec 26, 2023Nationwide• Haleon US Holdings LLC

Bleomycin Injection (Pfizer) – Glass Particulate Matter (2023)

Presence of particulate matter: glass

Class IHigh

FDADec 21, 2023Nationwide• PFIZER

Sodium Bicarbonate Injection (Pfizer) – Glass Particulate Matter (2023)

Presence of Particulate Matter; identified as glass

Class IHigh

FDADec 21, 2023Nationwide• Pfizer Inc.

Atropine Sulfate Injection (Pfizer) – Glass Particulate Matter (2023)

Presence of Particulate Matter; identified as glass

Class IHigh

FDADec 21, 2023Nationwide• Pfizer Inc.

Sodium Bicarbonate Injection (Pfizer) – Glass Particulate Matter (2023)

Presence of Particulate Matter; identified as glass

Class IHigh

FDADec 21, 2023Nationwide• Pfizer Inc.

Selenium Sulfide Shampoo (Private Label) – Stability Concerns (2023)

CGMP Deviations: Stability data does not support expiry date.

Class IIModerate

FDADec 13, 2023NJ• Private Label Partners, Inc.

Nystatin Powder 500 MU (Fagron) – Incorrect Strength Label (2023)

Labeling: Label Error on Declared Strength: Assay value on the label is incorrect.

Class IIModerate

FDADec 11, 2023Nationwide• Fagron, Inc

Nystatin Powder 5 BU (Fagron) – Incorrect Strength Label (2023)

Labeling: Label Error on Declared Strength: Assay value on the label is incorrect.

Class IIModerate

FDADec 11, 2023Nationwide• Fagron, Inc

Sertraline Tablets (Legacy) – Product Comingling Risk (2023)

CGMP Deviations: Inadequate line clearance which may result in a potential comingling of product.

Class IIModerate

FDADec 11, 2023AR, CA• Legacy Pharmaceutical Packaging LLC

Nystatin Powder 2 BU (Fagron) – Incorrect Strength Label (2023)

Labeling: Label Error on Declared Strength: Assay value on the label is incorrect.

Class IIModerate

FDADec 11, 2023Nationwide• Fagron, Inc

1...39 404142 43...82

Page 41 of 82Next

Browse Other Categories

Food Baby Products Pet Products Toys Electronics Household Vehicles Medical Devices Other